Events and presentations Featured March 10, 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference 2026 March 10, 2026 March 10, 2026 January 28, 2026 NMD Pharma at J. P. Morgan Healthcare Conference 2026 January 28, 2026 January 28, 2026 May 29, 2025 We’re proud to share a special video marking NMD Pharma’s 10-year anniversary May 29, 2025 May 29, 2025 February 27, 2025 NMD Pharma raises awareness ahead of Rare Disease Day, 2025 February 27, 2025 February 27, 2025 November 30, 2024 ClC-1 inhibition for improvement of muscle function in CMT webinar November 30, 2024 November 30, 2024 April 25, 2024 Watch Cure SMA's Clinical Trial Update Webinar with NMD Pharma April 25, 2024 April 25, 2024 March 21, 2024 NMD Pharma Publishes Comprehensive Data Package for NMD670 in Science Translational Medicine March 21, 2024 March 21, 2024 February 28, 2023 Rare Disease Day, 28 February 2023 February 28, 2023 February 28, 2023 October 11, 2022 Today we are able to announce positive topline data from our Phase I/IIa clinical trial of NMD670 in patients with Myasthenia Gravis October 11, 2022 October 11, 2022 August 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 1 August 16, 2022 August 16, 2022 August 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 2 August 16, 2022 August 16, 2022 August 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3 August 16, 2022 August 16, 2022 August 16, 2022 NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A August 16, 2022 August 16, 2022 July 7, 2022 An active future made possible by the power of science July 7, 2022 July 7, 2022
